title: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
abstract: BACKGROUND
  Background The leucine-rich repeat kinase 2 gene (LRRK2) harbours highly penetrant mutations that are linked to familial parkinsonism. However, the extent of its polymorphic variability in relation to risk of Parkinson's disease (PD) has not been assessed systematically. We therefore assessed the frequency of LRRK2 exonic variants in individuals with and without PD, to investigate the role of the variants in PD susceptibility.
  
  
  METHODS
  LRRK2 was genotyped in patients with PD and controls from three series (white, Asian, and Arab-Berber) from sites participating in the Genetic Epidemiology of Parkinson's Disease Consortium. Genotyping was done for exonic variants of LRRK2 that were identified through searches of literature and the personal communications of consortium members. Associations with PD were assessed by use of logistic regression models. For variants that had a minor allele frequency of 0·5% or greater, single variant associations were assessed, whereas for rarer variants information was collapsed across variants.
  
  
  RESULTS
  121 exonic LRRK2 variants were assessed in 15 540 individuals: 6995 white patients with PD and 5595 controls, 1376 Asian patients and 962 controls, and 240 Arab-Berber patients and 372 controls. After exclusion of carriers of known pathogenic mutations, new independent risk associations were identified for polymorphic variants in white individuals (M1646T, odds ratio 1·43, 95% CI 1·15-1·78; p=0·0012) and Asian individuals (A419V, 2·27, 1·35-3·83; p=0·0011). A protective haplotype (N551K-R1398H-K1423K) was noted at a frequency greater than 5% in the white and Asian series, with a similar finding in the Arab-Berber series (combined odds ratio 0·82, 0·72-0·94; p=0·0043). Of the two previously reported Asian risk variants, G2385R was associated with disease (1·73, 1·20-2·49; p=0·0026), but no association was noted for R1628P (0·62, 0·36-1·07; p=0·087). In the Arab-Berber series, Y2189C showed potential evidence of risk association with PD (4·48, 1·33-15·09; p=0·012).
  
  
  CONCLUSIONS
  The results for LRRK2 show that several rare and common genetic variants in the same gene can have independent effects on disease risk. LRRK2, and the pathway in which it functions, is important in the cause and pathogenesis of PD in a greater proportion of patients with this disease than previously believed. These results will help discriminate those patients who will benefit most from therapies targeted at LRRK2 pathogenic activity.
  
  
  BACKGROUND
  Michael J Fox Foundation and National Institutes of Health.
authors: Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA. ross.owen@mayo.edu
authors: Owen A
authors: OA
authors: Ross
authors: Alexandra I
authors: AI
authors: Soto-Ortolaza
authors: Michael G
authors: MG
authors: Heckman
authors: Jan O
authors: JO
authors: Aasly
authors: Nadine
authors: N
authors: Abahuni
authors: Grazia
authors: G
authors: Annesi
authors: Justin A
authors: JA
authors: Bacon
authors: Soraya
authors: S
authors: Bardien
authors: Maria
authors: M
authors: Bozi
authors: Alexis
authors: A
authors: Brice
authors: Laura
authors: L
authors: Brighina
authors: Christine
authors: C
authors: Van Broeckhoven
authors: Jonathan
authors: J
authors: Carr
authors: Marie-Christine
authors: MC
authors: Chartier-Harlin
authors: Efthimios
authors: E
authors: Dardiotis
authors: Dennis W
authors: DW
authors: Dickson
authors: Nancy N
authors: NN
authors: Diehl
authors: Alexis
authors: A
authors: Elbaz
authors: Carlo
authors: C
authors: Ferrarese
authors: Alessandro
authors: A
authors: Ferraris
authors: Brian
authors: B
authors: Fiske
authors: J Mark
authors: JM
authors: Gibson
authors: Rachel
authors: R
authors: Gibson
authors: Georgios M
authors: GM
authors: Hadjigeorgiou
authors: Nobutaka
authors: N
authors: Hattori
authors: John P A
authors: JP
authors: Ioannidis
authors: Barbara
authors: B
authors: Jasinska-Myga
authors: Beom S
authors: BS
authors: Jeon
authors: Yun Joong
authors: YJ
authors: Kim
authors: Christine
authors: C
authors: Klein
authors: Rejko
authors: R
authors: Kruger
authors: Elli
authors: E
authors: Kyratzi
authors: Suzanne
authors: S
authors: Lesage
authors: Chin-Hsien
authors: CH
authors: Lin
authors: Timothy
authors: T
authors: Lynch
authors: Demetrius M
authors: DM
authors: Maraganore
authors: George D
authors: GD
authors: Mellick
authors: Eugénie
authors: E
authors: Mutez
authors: Christer
authors: C
authors: Nilsson
authors: Grzegorz
authors: G
authors: Opala
authors: Sung Sup
authors: SS
authors: Park
authors: Andreas
authors: A
authors: Puschmann
authors: Aldo
authors: A
authors: Quattrone
authors: Manu
authors: M
authors: Sharma
authors: Peter A
authors: PA
authors: Silburn
authors: Young Ho
authors: YH
authors: Sohn
authors: Leonidas
authors: L
authors: Stefanis
authors: Vera
authors: V
authors: Tadic
authors: Jessie
authors: J
authors: Theuns
authors: Hiroyuki
authors: H
authors: Tomiyama
authors: Ryan J
authors: RJ
authors: Uitti
authors: Enza Maria
authors: EM
authors: Valente
authors: Simone
authors: S
authors: van de Loo
authors: Demetrios K
authors: DK
authors: Vassilatis
authors: Carles
authors: C
authors: Vilariño-Güell
authors: Linda R
authors: LR
authors: White
authors: Karin
authors: K
authors: Wirdefeldt
authors: Zbigniew K
authors: ZK
authors: Wszolek
authors: Ruey-Meei
authors: RM
authors: Wu
authors: Matthew J
authors: MJ
authors: Farrer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D005006:Ethnicity / Q000235:genetics; D005091:Exons / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study / Q000379:methods; D005838:Genotype; D006801:Humans; D007391:International Cooperation; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D012307:Risk Factors; D055815:Young Adult
chemical_list: C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases